UPMC Physician Resources
Neurostimulation of the Upper Airway: STAR Trial and UPMC Clinical Update
In this presentation, moderated by Dr. Bridget Hathaway, UPMC’s Dr. Ryan Soose reviews the background for new OSA treatment options, implant procedure from patient selection to surgical technique, updates on the STAR Trial data, and clinical results at the University of Pittsburgh since the FDA approval last year.
Upon completion of this activity, participants should be able to:
- Improve the patient selection for upper airway neurostimulation therapy for OSA in order to more appropriately screen for patients who would be most likely to benefit from treatment.
- Increase the management options for-refractory OSA by describing the current neurostimulation technology and associated advantages/disadvantagescornpan compared to sleep apnea treatment options.
- Improve OSA patient outcomes by implementing the latest clinical trials data on neurostimulation therapy into routine clinical practice.
- Kent DT, Lee JJ, Strollo PJ Jr, Soose RJ. Upper airway stimulation for OSA: Early adherence and outcome results of one center. Otolaryngol Head Neck Surg. 2016 Jul; 155(1): 188-93. doi:10.1177/0194599816636619. Epub 2016 Mar 15. PMID: 2698090
- Woodson BT, Soose RJ, Gillespie MB, Strohl KP, Maurer JT, de ries N, Steward DL, Baskin JZ, Sadr MS, Lin HS, Padhya TA, Mickelson S, Anderson WM, Vandervek n OM, Strollo PJ Jr, STAR Trial Investigators. Three-year outcomes of cranial nerve stimulation for obstructive sleep apnea: The STAR trial. Otolaryngol Head Neck Surg. 2016 Jan;154(1):181-8. doi: 1 .1177/0194599815616618. Epub 2015 Nov 17. PMID: 26577774
- Strollo PJ, Soose RJ, Maurer JT, de Vries N, Cornelius J, Froym vich 0, Hanson RD, Padhya TA, Steward DL, Gillespie MB, Woodson BT, Van de Heyning PH, Goetting MG, Vanderveken OM, Feldman N, Knaack L, Strohl KP; STAR Trial Group. Upper airw y stimulation for obstructive sleep apnea. N Engl J Med 2014 Jan 9;370(2):139-49. PMID: 2440105
Dr. Soose has financial interests with the following proprietary entity or entities producing health care goods or services as indicated below:
- Grant/Reseearch: Inspire Medical Systems, Inc.
- Consultant: Inspire Medical Systems, Inc.
Dr. Hathaway has reported no relevant relationships with proprietary entities producing health care goods or services.
All presenters disclosure of relevant financial relationships with any proprietary entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients is listed above. No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Pittsburgh School of Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Each physician should only claim credit commensurate with the extent of their participation in the activity. Other health care professionals are awarded (0.1) continuing education units (CEU) which are equivalent to 1 contact hour.
For your credit transcript, please access our website 4 weeks post-completion at http://ccehs.upmc.edu and follow the link to the Credit Transcript page. If you do not provide the last 5 digits of your SSN on the next page you will not be able to access a CME credit transcript. Providing your SSN is voluntary.
Release Date: 4/10/2017 | Last Modified On: 4/10/2017 | Expires: 4/10/2018